News
A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following ...
Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, ...
Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.
Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...
1hon MSN
As users panic over Mounjaro price hike, experts reveal how to keep using weight loss jabs for less
Yesterday, US pharmaceutical giant Lilly announced the cost would soar from September 1, with a month's supply of the highest ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
THE price of Mounjaro is set to soar, The Sun revealed yesterday – leaving slimmers desperate and worried at how they will ...
MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next ...
How will the Mounjaro price increase affect your cost? What have companies like Juniper, MedExpress and Asda Online Doctor ...
Mounjaro Is About to Get More Expensive in the UK: Here Are Cheaper Alternatives Available Right Now
Mounjaro's UK price will rise by 170% in September, prompting interest in cheaper alternatives like semaglutide for weight loss.
A guideline has recommended two key drugs be prescribed in all patients with type 2 diabetes who are at higher risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results